Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

vibroX-training in Endurance Trained Men

This study has been completed.
Information provided by (Responsible Party):
University of Zurich Identifier:
First received: May 25, 2012
Last updated: May 13, 2013
Last verified: May 2013
In endurance sports competitions such as cycling, an athlete's capacity to sustain submaximum power (i.e. endurance capacity) strongly influences overall race performance. Endurance capacity can be increased by both long, continuous endurance exercise at moderate oxygen consumption, and high-intensity (at or above peak oxygen consumption) interval training. However, it has also been shown that resistance exercise, if performed in addition to endurance exercise, can further enhance endurance capacity. The investigators have recently described a novel training method, which is based on combined vibration and resistance training and superimposed vascular occlusion. Based on the investigators previous results showing that this type of training leads to marked increases in endurance capacity in previously untrained young women, the investigators aim at investigating whether the method is also effective in increasing endurance capacity in highly endurance-trained young men, and whether the method leads to bigger improvements relative to resistance exercise alone. Besides the functional outcomes the investigators are also interested in the specificity of the cellular adaptations with respect to the two trainings methods.

Condition Intervention
Health Behavior
Other: vibrox- vs. resistance training

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Influence of vibroX-training on the Power-duration-relationship and Maximal Force in Relation to Conventional Resistance Training in Endurance Trained Men

Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • Change from baseline in Critical Power [ Time Frame: 2 month intervention ]
    The difference in changes in Critical Power [Watts] are compared between the vibrox- and resistance training group. For this purpose, participants complete pre and post training a cycling ramp test and 4 cycling constant load tests.

Enrollment: 30
Study Start Date: November 2011
Study Completion Date: December 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: vibrox training Other: vibrox- vs. resistance training
Comparison between two exercise interventions
Other Name: vibrox
Experimental: resistance training Other: vibrox- vs. resistance training
Comparison between two exercise interventions
Other Name: vibrox


Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Inclusion criteria:

  • male
  • no fever / no common cold at the beginning of the study
  • at least 4 endurance training sessions prior to beginning of study
  • age 18-35y
  • non-smoker
  • no cardiological / orthopedic problems
  • no pacemaker
  • fulfills health questionnaire's requirements

Exclusion criteria: female

  • fever / common cold at beginning of study
  • untrained condition (less than 4 endurance training sessions prior to the
  • beginning of the study)
  • age under 18 oder above 35y
  • smoker
  • cardiovascular or orthopedic problems
  • cardiac pacemaker
  • does not fulfill health questionnaire's requirements
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01672281

University Hospital Zurich, Division of Neurology
Zurich, ZH, Switzerland, 8091 Zurich
Sponsors and Collaborators
University of Zurich
Principal Investigator: Hans H. Jung, Professor MD University Hospital Zurich, Division of Neurology
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: University of Zurich Identifier: NCT01672281     History of Changes
Other Study ID Numbers: vbx
Study First Received: May 25, 2012
Last Updated: May 13, 2013 processed this record on May 25, 2017